Rhumbline Advisers Sells 33,518 Shares of Amdocs Limited $DOX

Rhumbline Advisers lessened its position in shares of Amdocs Limited (NASDAQ:DOX) by 13.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 221,163 shares of the technology company’s stock after selling 33,518 shares during the period. Rhumbline Advisers owned approximately 0.20% of Amdocs worth $18,146,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. Harbor Capital Advisors Inc. acquired a new position in Amdocs in the 3rd quarter valued at $26,000. Root Financial Partners LLC bought a new stake in shares of Amdocs in the third quarter valued at about $26,000. Atlantic Union Bankshares Corp acquired a new position in shares of Amdocs in the third quarter valued at about $37,000. Rossby Financial LCC bought a new position in Amdocs during the second quarter worth about $41,000. Finally, Caitong International Asset Management Co. Ltd raised its stake in Amdocs by 537.8% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock worth $43,000 after purchasing an additional 398 shares in the last quarter. Institutional investors own 92.02% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on DOX shares. Bank of America decreased their target price on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Stifel Nicolaus cut their target price on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research report on Thursday, November 13th. Finally, Barclays dropped their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $92.33.

Amdocs Price Performance

Amdocs stock opened at $68.42 on Wednesday. The stock’s 50 day moving average is $79.30 and its 200 day moving average is $81.48. Amdocs Limited has a one year low of $66.53 and a one year high of $95.41. The firm has a market cap of $7.39 billion, a P/E ratio of 13.23, a P/E/G ratio of 1.23 and a beta of 0.40. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.17.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The firm had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the previous year, the company earned $1.66 EPS. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, research analysts expect that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be given a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a dividend yield of 3.3%. The ex-dividend date is Tuesday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s dividend payout ratio is currently 40.81%.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.